We are live on ! Find out more
CBST

CUBIST PHARMACEUTICALS INC
CBST

Delisted

CBST was delisted on the 21st of January, 2015.

254 hedge funds and large institutions have $5.31B invested in CUBIST PHARMACEUTICALS INC in 2014 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 105 increasing their positions, 91 reducing their positions, and 38 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 105 | Existing positions reduced: 91

3% less capital invested

Capital invested by funds: $5.5B → $5.31B (-$188M)

6% less funds holding

Funds holding: 270254 (-16)

18% less call options, than puts

Call options by funds: $35.7M | Put options by funds: $43.4M

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

34% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 38

Holders
254
Holders Change
-16
Holders Change %
-5.93%
% of All Funds
7.37%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.17%
New
25
Increased
105
Reduced
91
Closed
38
Calls
$35.7M
Puts
$43.4M
Net Calls
-$7.72M
Net Calls Change
+$422M
Name Holding Trade Value Shares
Change
Change in
Stake
PI
151
Placemark Investments
Illinois
$1.43M +$97.3K +1,481 +7%
MERSOM
152
Municipal Employees' Retirement System of Michigan
Michigan
$1.41M +$52.5K +800 +4%
ERSOT
153
Employees Retirement System of Texas
Texas
$1.39M
AAM
154
Advisors Asset Management
Colorado
$1.39M +$43.7K +666 +3%
LSERS
155
Louisiana State Employees Retirement System
Louisiana
$1.36M +$13.1K +200 +1%
MC
156
Middleton & Co
Massachusetts
$1.33M +$40.1K +610 +3%
Ohio Public Employees Retirement System (OPERS)
157
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.33M -$237K -3,605 -15%
PSUF
158
People's United Financial
Connecticut
$1.22M +$29.4K +448 +2%
RJA
159
Raymond James & Associates
Florida
$1.1M +$106K +1,611 +11%
BlackRock
160
BlackRock
New York
$1.04M +$199K +3,029 +24%
SLG
161
Stanley-Laman Group
Pennsylvania
$1.03M -$65.3K -994 -6%
IRF
162
IBM Retirement Fund
New York
$1.02M -$139K -2,116 -12%
WT
163
Whittier Trust
California
$1M
PP
164
PDT Partners
New York
$985K -$1.18M -18,009 -55%
JGUA
165
John G. Ullman & Associates
New York
$940K -$29.9K -455 -3%
American Century Companies
166
American Century Companies
Missouri
$889K +$278K +4,226 +46%
URS
167
Utah Retirement Systems
Utah
$863K
Credit Agricole
168
Credit Agricole
France
$854K +$241K +3,662 +40%
KBC Group
169
KBC Group
Belgium
$845K -$286K -4,360 -25%
USAA
170
United Services Automobile Association
Texas
$837K
AIP
171
Ameritas Investment Partners
Nebraska
$744K
ARTA
172
A.R.T. Advisors
New York
$729K -$1.48M -22,498 -67%
SAM
173
Securian Asset Management
Minnesota
$710K +$12.7K +193 +2%
COPPSERS
174
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$697K +$2.63K +40 +0.4%
IPC
175
Independent Portfolio Consultants
Florida
$665K +$139K +2,110 +27%

CBST Hedge Fund Activity: Q3 2014 in Review

254 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in CUBIST PHARMACEUTICALS INC (CBST) for Q3 2014, worth a combined $5.31B — down 3.4% from $5.5B a quarter earlier.

Sellers outnumbered buyers: 38 funds closed out of CBST and 25 opened new positions — a net loss of 13 holders — while 91 trimmed existing stakes and 105 added.

The largest buyer was PointState Capital, adding an estimated $61.1M. The largest seller was OppenheimerFunds, exiting entirely with an estimated $39.6M sold.

  • 254 institutional investors held CUBIST PHARMACEUTICALS INC (CBST) as of Q3 2014, down from 270 in Q2 2014.
  • Funds reported $5.31B of CUBIST PHARMACEUTICALS INC stock for Q3 2014, down 3.4% quarter-over-quarter.
  • 25 funds opened new CUBIST PHARMACEUTICALS INC positions in Q3 2014 and 38 closed out, a net change of -13 holders.
  • The largest CUBIST PHARMACEUTICALS INC buyer in Q3 2014 was PointState Capital, an estimated $61.1M added.
  • The largest CUBIST PHARMACEUTICALS INC seller in Q3 2014 was OppenheimerFunds, an estimated $39.6M sold.

Based on aggregated 13F filings for Q3 2014.